Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-02 4:30 pm Purchase | 2022-11-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA CAPITAL MANAGEMENT L.P. | 4,333,333 5.290% | 4,333,333 (New Position) | Filing History |
| 2022-11-28 4:31 pm Purchase | 2022-11-17 | 13D | Acrivon Therapeutics, Inc. Common Stock ACRV | RA CAPITAL MANAGEMENT L.P. | 4,813,442 23.070% | 4,813,442 (New Position) | Filing History |
| 2022-11-14 4:46 pm Purchase | 2022-11-10 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 556,565 28.780% | 516 (+0.09%) | Filing History |
| 2022-11-14 4:43 pm Unchanged | 2022-11-14 | 13G | Standard BioTools Inc. LAB | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | LianBio LIANY | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -7,655,015 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Veru Inc. VERU | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -790,000 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,262,193 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Dyne Therapeutics, Inc. DYN | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,805,045 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Larimar Therapeutics, Inc. LRMR | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,334,610 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Unchanged | 2022-11-14 | 13G | Olema Pharmaceuticals, Inc. OLMA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Otonomy, Inc. OTIC | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,600,000 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Xilio Therapeutics, Inc. XLO | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,002,217 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -969,479 (Position Closed) | Filing History |
| 2022-10-24 4:43 pm Purchase | 2022-10-14 | 13G | Bitwise MARA Option Income Strategy ETF IMRA | RA CAPITAL MANAGEMENT L.P. | 805,206 12.250% | 805,206 (New Position) | Filing History |
| 2022-10-21 06:03 am Purchase | 2022-10-18 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 9,376,402 19.900% | 1,570,233 (+20.12%) | Filing History |
| 2022-10-19 4:37 pm Purchase | 2022-10-17 | 13D | DICE Therapeutics, Inc. DICE | RA CAPITAL MANAGEMENT L.P. | 6,848,911 14.400% | 1,640,000 (+31.48%) | Filing History |
| 2022-10-17 5:21 pm Purchase | 2022-10-07 | 13G | Inhibrx Biosciences, Inc. INBX | RA CAPITAL MANAGEMENT L.P. | 3,185,831 8.160% | 3,185,831 (New Position) | Filing History |
| 2022-10-17 4:31 pm Purchase | 2022-10-05 | 13G | Adicet Bio, Inc. ACET | RA CAPITAL MANAGEMENT L.P. | 147,772 5.500% | 147,772 (New Position) | Filing History |
| 2022-10-14 4:03 pm Sale | 2022-10-14 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -9,040,309 (Position Closed) | Filing History |
| 2022-10-13 4:30 pm Purchase | 2022-10-03 | 13G | Design Therapeutics, Inc. DSGN | RA CAPITAL MANAGEMENT L.P. | 2,971,231 5.320% | 2,971,231 (New Position) | Filing History |